drugset / Trial / NCT01148576
Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To investigate the influence of hepatic steatosis on the anti-viral effect of entecavir in chronic hepatitis B patients.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-12
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 0.5 mg | — |
| Subject | Polyene Phosphatidylcholine | Small molecule | 1 unknown | — |
| Subject | Vitamin E | Other / unclassified | 100 mg | — |